Whan In PharmLtd Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Wonbum Lee
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 19.9yrs |
| CEO ownership | 16.2% |
| Management average tenure | no data |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Did Whan In Pharm Co.,Ltd. (KRX:016580) Use Debt To Deliver Its ROE Of 7.8%?
Mar 15
Here's Why I Think Whan In PharmLtd (KRX:016580) Might Deserve Your Attention Today
Feb 25Whan In Pharm Co.,Ltd.'s (KRX:016580) 1.6% Dividend Yield Looks Pretty Interesting
Feb 04
What Is The Ownership Structure Like For Whan In Pharm Co.,Ltd. (KRX:016580)?
Jan 14Why You Might Be Interested In Whan In Pharm Co.,Ltd. (KRX:016580) For Its Upcoming Dividend
Dec 24Does Whan In Pharm Co.,Ltd. (KRX:016580) Create Value For Shareholders?
Dec 11Whan In PharmLtd's (KRX:016580) Shareholders Are Down 33% On Their Shares
Nov 20CEO
Wonbum Lee (51 yo)
Mr. Wonbum Lee serves as the Chief Executive Officer and the President at Whan In Pharm Co.,Ltd and serves as its Director. Mr. Lee served as Vice President of Whan In Pharm Co.,Ltd. He served as the Head...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | no data | ₩936.00m | 12.19% ₩ 21.6b | |
| CEO, President & Director | 19.9yrs | no data | 16.17% ₩ 28.7b | |
| Independent Outside Director | 5.8yrs | no data | no data | |
| Independent Outside Director | 3.8yrs | no data | no data | |
| Independent Outside Director | 1.8yrs | no data | no data |
Experienced Board: A016580's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/14 05:03 |
| End of Day Share Price | 2025/12/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Whan In Pharm Co.,Ltd. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Seung-Ho Lee | iM Securities |
| Hong-Sik Jeong | LS Securities Co., Ltd. |
| Woo-sung Jung | LS Securities Co., Ltd. |